Literature DB >> 8347159

Alkylation of human albumin by the antimalarial artemisinin.

Y Z Yang1, W Asawamahasakda, S R Meshnick.   

Abstract

The interaction between artemisinin and human serum was studied in vitro using [3H]dihydroartemisinin and [14C]artemisinin. Approximately 20% of added drug was covalently bound to albumin in 24 hr. The results of electrospray ionization mass spectra showed that albumin had an M(r) value of 66,745 +/- 35 and the drug-bound albumin had an M(r) of 67,223 +/- 34. The binding was blocked 15 and 58% by iodoacetamide (IA) and N-ethylmaleimide, respectively, and 80% by the combination of IA and succinic anhydride. Hemin and Fe2+ increased the binding by 40 and 10%, respectively, whereas deferoxamine inhibited the binding by 10%. Therefore, we conclude that the binding between artemisinin and albumin probably involves thiol and amino groups via both iron-dependent and -independent reactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347159     DOI: 10.1016/0006-2952(93)90425-v

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Artemisinin and heme.

Authors:  Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

2.  Interaction of artemisinin and its derivatives with human serum albumin studied using spectroscopies and molecular modeling methods.

Authors:  Rongrong Chen; Hua Jiang; Hanlin Pu
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

3.  Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species.

Authors:  Anusha M Gopalakrishnan; Nirbhay Kumar
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

4.  Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunate.

Authors:  W Ittarat; S Looareesuwan; P Pootrakul; P Sumpunsirikul; P Vattanavibool; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 5.  Pharmacokinetics of artemisinin-type compounds.

Authors:  V Navaratnam; S M Mansor; N W Sit; J Grace; Q Li; P Olliaro
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

Review 6.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

Authors:  S R Meshnick; T E Taylor; S Kamchonwongpaisan
Journal:  Microbiol Rev       Date:  1996-06

7.  Reaction of antimalarial endoperoxides with specific parasite proteins.

Authors:  W Asawamahasakda; I Ittarat; Y M Pu; H Ziffer; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

Review 8.  Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations.

Authors:  G Edwards; P A Winstanley; S A Ward
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

Review 9.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05

10.  Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells.

Authors:  Kodihalli C Ravindra; Wanxing Eugene Ho; Chang Cheng; Luiz C Godoy; John S Wishnok; Choon Nam Ong; W S Fred Wong; Gerald N Wogan; Steven R Tannenbaum
Journal:  Chem Res Toxicol       Date:  2015-09-21       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.